BIOCON

Biocon Balance Sheet

₹360.10-2.44%
Market cap
₹58,318 crore
P/E
117.7
P/B
1.71
ROE
1.4%
Dividend yield
0.14%

As of Mar 2022, Biocon had total assets of ₹13,700 crore and borrowings of ₹1,200 crore, against shareholders' equity of ₹9,000 crore — a debt-to-equity ratio of 0.13. Borrowings fell 93.34% from Mar 2023.

Biocon balance sheet

As at each financial year end, newest first. H1 = half-year.

Biocon balance sheet (₹ crore)
ItemMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital500600600600811
Reserves8,50016,08617,60318,95913,992
Borrowings1,20018,01916,27718,36215,434
Other liabilities3,50011,53514,51912,72311,595
Total liabilities13,70052,04356,07158,79763,651
Fixed assets6,50010,12312,20813,60814,734
Capital work in progress400100100100100
Investments2,50053811,21411,75912,730
Other assets4,30015,61316,82117,63919,095
Total assets13,70052,04356,07158,79763,651

Balance sheet ratios

Debt to equity
0.13

Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Biocon balance sheet — frequently asked questions

What is the total debt of Biocon?

Biocon reported borrowings of ₹1,200 crore as of Mar 2022, compared with ₹18,019 crore as of Mar 2023.

What is Biocon's debt-to-equity ratio?

Based on the Mar 2022 balance sheet, Biocon's debt-to-equity ratio is 0.13 — borrowings of ₹1,200 crore against equity capital and reserves of ₹9,000 crore.

What are Biocon's total assets?

Biocon's total assets were ₹13,700 crore as of Mar 2022, including fixed assets of ₹6,500 crore and investments of ₹2,500 crore.

Same Data For Peers

Trade Biocon With ATS

Track BIOCON live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.